FeesSafety
Pluang+

NextPlat to release Q3 2026 financial results on Nov 12 with live investor call.

Company Fundamentals
06 Nov 2026, 20:08 WIB
PRNewsWire
View Source
Neutral
NextPlat to release Q3 2026 financial results on Nov 12 with live investor call.

NextPlat Corp will announce its financial results for the third quarter ending September 30, 2026, on November 12, 2026. The company's CEO, CFO, and VP of Healthcare Operations will host a conference call at 8:30 a.m. Eastern to discuss the results and recent developments. Investors can join the call via phone or webcast and submit questions before November 10. A replay will be available until November 26. This update provides insight into NextPlat's ongoing business performance in healthcare and technology sectors.

NextPlat's upcoming Q3 2026 results announcement provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 06, 2026 23:12 WIB: among 150 priced US health stocks, 76 rose and 72 fell. Notable movers include ELAN (Elanco Animal Health Incorporated) up 6.72% at USD 25.26 with a typical hold time of 28 days, DFTX (Definium Therapeutics Inc.) up 6.39% at USD 32.30 with a typical hold time of 15 days and a 57% sell order activity, and XRAY (DENTSPLY SIRONA Inc.) down 6.14% at USD 9.47 with a typical hold time of 74 days.

More News

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...

Company Fundamentals
Neutral
2 hours ago
Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...

Company Fundamentals
Neutral
2 hours ago
Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...

Market News
Bullish
2 hours ago
Sodexo reports October 2026 share capital and voting rights update.

Sodexo reports October 2026 share capital and voting rights update.

Sodexo disclosed its monthly update on share capital and voting rights as of October 31, 2026. The company has 147,454,887 shares with actual voting rights totaling 216,485,145, reflecting shares with single and double voting rights. This update is p...

Company Fundamentals
Neutral
2 hours ago
Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo announced its monthly update on the total number of shares and voting rights as of October 31, 2026. The company has 147,454,887 shares composing its capital, with 216,485,145 exercisable voting rights and 218,335,896 theoretical voting rights...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App